The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo)
Abstract
Objective: Quality of survival, prognosis and long-term outcome are often severely impaired in childhood-onset craniopharyngioma (CP) patients. Identification of risk factors for sequelae such as growth hormone (GH) deficiency is important for appropriate treatment and rehabilitation. Design: In a cross-sectional study, 79 CP patients recruited in HIT-Endo before 2000 were analyzed according to GH substitution: (a) CP never GH treated (noGH); (b) CP GH treated only during childhood (pedGH); (c) CP under GH, initiated at adulthood (adultGH); (d) CP under GH during childhood and continued during adulthood (contGH). Methods: Progression-free (PFS) and overall survival (OS), height, BMI, psychosocial and neuropsychological status (EORTC QLQ-C30, MFI-20). Results: OS and PFS rates were similar in all subgroups. ContGH and pedGH CP presented with increases in height (P = 0.002;P = 0.0001) during long-term follow-up when compared with baseline. In all subgroups except for pedGH, increases in BMI were observed when compared with BMI at diagnosis. For emotional functionality and physical fatigue, adultGH CP showed worse (P = 0.037;P = 0.034) response (mean: 61.4%; 12.5%) when compared with pedGH CP (mean: 83.5%; 7.7%). Observed differences were not related to irradiation and hypothalamic involvement. In terms of psychosocial status, no differences were observed between subgroups. Conclusions: We conclude that GH substitution was safe with regard to risk of tumor progression/relapse in CP. Growth was improved by GH, whereas the development of obesity was not influenced by GH substitution. However, early initiation of GH substitution after CP diagnosis might have beneficial effects on weight development and neuropsychological outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For hypothalamic patients specifically, GH treatment has been shown to decrease BMI and improve body composition, especially when given during childhood (163, 164).”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
Karavitaki, N., Brufani, C., Warner, J. T., Adams, C. B. T., Richards, P., Ansorge, O., Shine, B., Turner, H. E., & Wass, J. A. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02231.x · Cited by 633
Features of the metabolic syndrome after childhood craniopharyngioma
Srinivasan, S., Ogle, G. D., Garnett, S. P., Briody, J. N., Lee, J. W., & Cowell, C. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030442 · Cited by 211
Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement
Özyurt, J., Thiel, C. M., Lorenzen, A., Gebhardt, U., Calaminus, G., Warmuth-Metz, M., & Müller, H. L. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.12.010 · Cited by 79
Research works printed but not linked: 117
- 2014, Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience, International Journal of Radiation Oncology, Biology, Physics, 88, 1011, 10.1016/j.ijrobp.2014.01.019 · DOI
- 2003, Improvements in final height over 25 years in Growth Hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement, Journal of Clinical Endocrinology and Metabolism, 88, 3682, 10.1210/jc.2003-030366 · DOI
- 2002, Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status – 3-year results from the HypoCCS Database, Journal of Clinical Endocrinology and Metabolism, 87, 1600
- 2011, Consequences of craniopharyngioma surgery in children, Journal of Clinical Endocrinology and Metabolism, 96, 1981, 10.1210/jc.2011-0174 · DOI · Paper page
- 2014, Childhood craniopharyngioma – changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007, Klinische Padiatrie, 226, 161, 10.1055/s-0034-1368785 · DOI · Paper page
- 2018, Craniopharyngioma – a chronic disease, Swiss Medical Weekly, 148, w14548
- 2015, Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma, Journal of Pediatric Endocrinology and Metabolism, 28, 35
- 2010, Health status in long-term survivors of pediatric craniopharyngiomas, Journal of Neuroscience Nursing, 42, 323, 10.1097/JNN.0b013e3181f8a59d · DOI
- 2005, The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma, European Journal of Endocrinology, 152, 557, 10.1530/eje.1.01877 · DOI
- 2015, Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden, Journal of Clinical Endocrinology and Metabolism, 100, 467, 10.1210/jc.2014-3525 · DOI · Paper page
- 2009, Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy, European Journal of Endocrinology, 161, 671, 10.1530/EJE-09-0449 · DOI
- 2006, Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma, Klinische Padiatrie, 218, 315, 10.1055/s-2006-942249 · DOI
- 1996, Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging, Journal of Clinical Endocrinology and Metabolism, 81, 2734
- 2010, Childhood craniopharyngioma – current concepts in diagnosis, therapy and follow-up, Nature Reviews Endocrinology, 6, 609, 10.1038/nrendo.2010.168 · DOI · Paper page
- 2018, Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on Growth Hormone replacement, Journal of Clinical Endocrinology and Metabolism, 103, 768, 10.1210/jc.2017-01542 · DOI
- 1993, The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, Journal of the National Cancer Institute, 85, 365, 10.1093/jnci/85.5.365 · DOI · Paper page
- 2011, Long-term clinical outcomes following treatment of childhood craniopharyngioma, Pediatric Blood and Cancer, 56, 1120, 10.1002/pbc.22884 · doi:10.1002/pbc.22884
- 2003, Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma, Klinische Padiatrie, 215, 310, 10.1055/s-2003-45499 · DOI
- 2001, A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices, Journal of Clinical Endocrinology and Metabolism, 86, 4657, 10.1210/jcem.86.10.7887 · doi:10.1210/jcem.86.10.7887 · Paper page
- 2015, Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes, Neuro-Oncology, 17, 1029, 10.1093/neuonc/nov044 · DOI · Paper page
- 2012, Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations, Journal of Clinical Endocrinology and Metabolism, 97, 3935, 10.1210/jc.2012-2069 · DOI · Paper page
- 1998, Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence, Journal of Clinical Endocrinology and Metabolism, 83, 3897
- 2014, Childhood craniopharyngioma – changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007, Klinische Padiatrie, 226, 161, 10.1055/s-0034-1368785 · DOI · Paper page
- 2014, Craniopharyngioma, Endocrine Reviews, 35, 513, 10.1210/er.2013-1115 · DOI · Paper page
- 2013, Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction, European Journal of Endocrinology, 169, 511, 10.1530/EJE-13-0280 · DOI
- 2018, Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on Growth Hormone replacement, Journal of Clinical Endocrinology and Metabolism, 103, 768, 10.1210/jc.2017-01542 · DOI
- 2001, Obesity after childhood craniopharyngioma – German multicenter study on pre-operative risk factors and quality of life, Klinische Padiatrie, 213, 244, 10.1055/s-2001-16855 · DOI · Paper page
- 2011, Consequences of craniopharyngioma surgery in children, Journal of Clinical Endocrinology and Metabolism, 96, 1981, 10.1210/jc.2011-0174 · DOI · Paper page
- 2013, Childhood craniopharyngioma, Pituitary, 16, 56, 10.1007/s11102-012-0401-0 · DOI
- 2004, Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma, Journal of Clinical Endocrinology and Metabolism, 89, 3298, 10.1210/jc.2003-031751 · DOI · Paper page
- 2010, Analyses of treatment variables for patients with childhood craniopharyngioma – results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up, Hormone Research in Paediatrics, 73, 175, 10.1159/000284358 · DOI
- 2011, Improvements in behaviour and self-esteem following Growth Hormone treatment in short prepubertal children, Hormone Research in Paediatrics, 75, 291, 10.1159/000322937 · DOI · Paper page
- 2018, The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up, European Journal of Endocrinology, 178, 11, 10.1530/EJE-17-0387 · DOI
- 1998, Efficacy and safety of Growth Hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996, Hormone Research, 49, 91, 10.1159/000023133 · DOI
- 2014, Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement, Jurnalul Pediatrului, 164, 876.e874
- 2017, Patterns of care and treatment outcomes of patients with craniopharyngioma in the national cancer database, Journal of Neuro-Oncology, 132, 109, 10.1007/s11060-016-2342-3 · DOI
- 2016, Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study, Journal of Neurosurgery: Pediatrics, 18, 408
- 1996, Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging, Journal of Clinical Endocrinology and Metabolism, 81, 2734
- 2015, Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden, Journal of Clinical Endocrinology and Metabolism, 100, 467, 10.1210/jc.2014-3525 · DOI · Paper page
- 2002, Craniopharyngioma in adults and children: a study of 122 surgical cases, Journal of Neurological Surgery, 97, 3
- 2011, Long-term clinical outcomes following treatment of childhood craniopharyngioma, Pediatric Blood and Cancer, 56, 1120, 10.1002/pbc.22884 · doi:10.1002/pbc.22884
- 2017, Very long-term sequelae of craniopharyngioma, European Journal of Endocrinology, 176, 755, 10.1530/EJE-17-0044 · DOI
- 2001, Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study, Journal of Clinical Endocrinology and Metabolism, 86, 4693, 10.1210/jcem.86.10.7896 · DOI
- 2013, Childhood craniopharyngioma, Pituitary, 16, 56, 10.1007/s11102-012-0401-0 · DOI
- 2014, Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience, International Journal of Radiation Oncology, Biology, Physics, 88, 1011, 10.1016/j.ijrobp.2014.01.019 · DOI
- 1998, Efficacy and safety of Growth Hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996, Hormone Research, 49, 91, 10.1159/000023133 · DOI
- 2003, Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma, Klinische Padiatrie, 215, 310, 10.1055/s-2003-45499 · DOI
- 2005, Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up, Clinical Endocrinology, 62, 397, 10.1111/j.1365-2265.2005.02231.x · DOI · Paper page
- 2002, Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001, International Journal of Radiation Oncology, Biology, Physics, 53, 533, 10.1016/S0360-3016(02)02799-2 · DOI · Paper page
- 2018, Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma, Journal of Neuro-Oncology
- 2002, Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status – 3-year results from the HypoCCS Database, Journal of Clinical Endocrinology and Metabolism, 87, 1600
- 2003, Improvements in final height over 25 years in Growth Hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement, Journal of Clinical Endocrinology and Metabolism, 88, 3682, 10.1210/jc.2003-030366 · DOI
- 2010, Health status in long-term survivors of pediatric craniopharyngiomas, Journal of Neuroscience Nursing, 42, 323, 10.1097/JNN.0b013e3181f8a59d · DOI
- 2011, Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series, Journal of Neurological Surgery, 114, 1350
- 2001, Obesity after childhood craniopharyngioma – German multicenter study on pre-operative risk factors and quality of life, Klinische Padiatrie, 213, 244, 10.1055/s-2001-16855 · DOI · Paper page
- 2004, Outcome of craniopharyngioma in children: long-term complications and quality of life, Developmental Medicine and Child Neurology, 46, 220, 10.1111/j.1469-8749.2004.tb00476.x · DOI · Paper page
- 2005, High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma, Clinical Endocrinology, 62, 197, 10.1111/j.1365-2265.2004.02196.x · DOI · Paper page
- 2014, Craniopharyngioma, Endocrine Reviews, 35, 513, 10.1210/er.2013-1115 · DOI · Paper page
- 2018, Craniopharyngioma – a chronic disease, Swiss Medical Weekly, 148, w14548
- 2004, Outcome of craniopharyngioma in children: long-term complications and quality of life, Developmental Medicine and Child Neurology, 46, 220, 10.1111/j.1469-8749.2004.tb00476.x · DOI · Paper page
- 2010, Analyses of treatment variables for patients with childhood craniopharyngioma – results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up, Hormone Research in Paediatrics, 73, 175, 10.1159/000284358 · DOI
- 2017, Very long-term sequelae of craniopharyngioma, European Journal of Endocrinology, 176, 755, 10.1530/EJE-17-0044 · DOI
- 2011, Improvements in behaviour and self-esteem following Growth Hormone treatment in short prepubertal children, Hormone Research in Paediatrics, 75, 291, 10.1159/000322937 · DOI · Paper page
- 2012, Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients, Journal of Clinical Endocrinology and Metabolism, 97, 1258, 10.1210/jc.2011-2817 · DOI
- 2012, Hypothalamic obesity in children, Obesity Reviews, 13, 780, 10.1111/j.1467-789X.2012.01004.x · DOI
- 1993, The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, Journal of the National Cancer Institute, 85, 365, 10.1093/jnci/85.5.365 · DOI · Paper page
- 2013, Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction, European Journal of Endocrinology, 169, 511, 10.1530/EJE-13-0280 · DOI
- 2006, Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma, Klinische Padiatrie, 218, 315, 10.1055/s-2006-942249 · DOI
- 2005, High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma, Clinical Endocrinology, 62, 197, 10.1111/j.1365-2265.2004.02196.x · DOI · Paper page
- 2001, A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices, Journal of Clinical Endocrinology and Metabolism, 86, 4657, 10.1210/jcem.86.10.7887 · doi:10.1210/jcem.86.10.7887 · Paper page
- 2004, Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults, International Journal of Radiation Oncology, Biology, Physics, 58, 714, 10.1016/S0360-3016(03)01570-0 · DOI · Paper page
- 2005, Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital, Child’s Nervous System, 21, 729, 10.1007/s00381-005-1202-9 · DOI · Paper page
- 2015, Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes, Neuro-Oncology, 17, 1029, 10.1093/neuonc/nov044 · DOI · Paper page
- 2018, Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma, Journal of Neuro-Oncology
- 2012, Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients, Journal of Clinical Endocrinology and Metabolism, 97, 1258, 10.1210/jc.2011-2817 · DOI
- 2018, Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study, European Journal of Endocrinology, 178, 95
- 2018, The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up, European Journal of Endocrinology, 178, 11, 10.1530/EJE-17-0387 · DOI
- 2009, Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy, European Journal of Endocrinology, 161, 671, 10.1530/EJE-09-0449 · DOI
- 2006, Growth Hormone treatment and risk of second neoplasms in the childhood cancer survivor, Journal of Clinical Endocrinology and Metabolism, 91, 3494, 10.1210/jc.2006-0656 · DOI · Paper page
- 2018, Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007, Endocrine, 59, 364, 10.1007/s12020-017-1489-9 · DOI · Paper page
- 2011, Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up, European Journal of Endocrinology, 165, 17, 10.1530/EJE-11-0158 · DOI · Paper page
- 2002, Craniopharyngioma in adults and children: a study of 122 surgical cases, Journal of Neurological Surgery, 97, 3
- 2004, Features of the metabolic syndrome after childhood craniopharyngioma, Journal of Clinical Endocrinology and Metabolism, 89, 81, 10.1210/jc.2003-030442 · DOI · Paper page
- 2005, Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital, Child’s Nervous System, 21, 729, 10.1007/s00381-005-1202-9 · DOI · Paper page
- 1991, Body mass index variations: centiles from birth to 87 years, European Journal of Clinical Nutrition, 45, 13
- 2008, Hypothalamic obesity: causes, consequences, treatment, Pediatric Endocrinology Reviews, 6, 220
- 1993, 20-year experience in childhood craniopharyngioma, International Journal of Radiation Oncology, Biology, Physics, 27, 189, 10.1016/0360-3016(93)90227-M · DOI · Paper page
- 2018, Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study, European Journal of Endocrinology, 178, 95
- 2018, Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007, Endocrine, 59, 364, 10.1007/s12020-017-1489-9 · DOI · Paper page
- 1998, Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence, Journal of Clinical Endocrinology and Metabolism, 83, 3897
- 2017, The neuroendocrine sequelae of paediatric craniopharyngioma: a 40-year meta-data analysis of 185 cases from three UK centres, European Journal of Endocrinology, 176, 359, 10.1530/EJE-16-0812 · DOI
- 2015, Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma, Journal of Pediatric Endocrinology and Metabolism, 28, 35
- 2016, Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study, Journal of Neurosurgery: Pediatrics, 18, 408
- 2012, Hypothalamic obesity in children, Obesity Reviews, 13, 780, 10.1111/j.1467-789X.2012.01004.x · DOI
- 2017, New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma, Nature Reviews Endocrinology, 13, 299, 10.1038/nrendo.2016.217 · DOI · Paper page
- 1989, Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development, Helvetica Paediatrica Acta: Supplementum, 52, 1
- 2006, Growth Hormone treatment and risk of second neoplasms in the childhood cancer survivor, Journal of Clinical Endocrinology and Metabolism, 91, 3494, 10.1210/jc.2006-0656 · DOI · Paper page
- 1994, Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma – a 20-year experience, Pediatric Neurosurgery, 21, 75, 10.1159/000120866 · DOI
- 2011, Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series, Journal of Neurological Surgery, 114, 1350
- 2004, Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults, International Journal of Radiation Oncology, Biology, Physics, 58, 714, 10.1016/S0360-3016(03)01570-0 · DOI · Paper page
- 2001, Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study, Journal of Clinical Endocrinology and Metabolism, 86, 4693, 10.1210/jcem.86.10.7896 · DOI
- 2012, Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations, Journal of Clinical Endocrinology and Metabolism, 97, 3935, 10.1210/jc.2012-2069 · DOI · Paper page
- 2011, Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up, European Journal of Endocrinology, 165, 17, 10.1530/EJE-11-0158 · DOI · Paper page
- 2004, Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma, Journal of Clinical Endocrinology and Metabolism, 89, 3298, 10.1210/jc.2003-031751 · DOI · Paper page
- 1993, 20-year experience in childhood craniopharyngioma, International Journal of Radiation Oncology, Biology, Physics, 27, 189, 10.1016/0360-3016(93)90227-M · DOI · Paper page
- 2017, New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma, Nature Reviews Endocrinology, 13, 299, 10.1038/nrendo.2016.217 · DOI · Paper page
- 1989, Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development, Helvetica Paediatrica Acta: Supplementum, 52, 1
- 2010, Childhood craniopharyngioma – current concepts in diagnosis, therapy and follow-up, Nature Reviews Endocrinology, 6, 609, 10.1038/nrendo.2010.168 · DOI · Paper page
- 2005, The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma, European Journal of Endocrinology, 152, 557, 10.1530/eje.1.01877 · DOI
- 1995, The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue, Journal of Psychosomatic Research, 39, 315, 10.1016/0022-3999(94)00125-O · DOI · Paper page
- 2008, Hypothalamic obesity: causes, consequences, treatment, Pediatric Endocrinology Reviews, 6, 220
- 1994, Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma – a 20-year experience, Pediatric Neurosurgery, 21, 75, 10.1159/000120866 · DOI
- 2017, The neuroendocrine sequelae of paediatric craniopharyngioma: a 40-year meta-data analysis of 185 cases from three UK centres, European Journal of Endocrinology, 176, 359, 10.1530/EJE-16-0812 · DOI
- 1991, Body mass index variations: centiles from birth to 87 years, European Journal of Clinical Nutrition, 45, 13
- 2002, Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001, International Journal of Radiation Oncology, Biology, Physics, 53, 533, 10.1016/S0360-3016(02)02799-2 · DOI · Paper page
- 1995, The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue, Journal of Psychosomatic Research, 39, 315, 10.1016/0022-3999(94)00125-O · DOI · Paper page
- 2017, Patterns of care and treatment outcomes of patients with craniopharyngioma in the national cancer database, Journal of Neuro-Oncology, 132, 109, 10.1007/s11060-016-2342-3 · DOI
Cited by
Müller, H. L., Merchant, T. E., Warmuth-Metz, M., Martinez-Barbera, J.-P., & Puget, S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0125-9 · Cited by 515
Self-citationMüller, H. L., Tauber, M., Lawson, E. A., Özyurt, J., Bison, B., Martinez-Barbera, J.-P., Puget, S., Merchant, T. E., & van Santen, H. M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00351-z · Cited by 144
Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update
Romigi, A., Feola, T., Cappellano, S., De Angelis, M., Pio, G., Caccamo, M., Testa, F., Vitrani, G., Centonze, D., Colonnese, C., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.817257 · Cited by 28
A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
Craven, M., Crowley, J. H., Chiang, L., Kline, C., Malbari, F., Hocking, M. C., & McCormack, S. E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.876770 · Cited by 21
van Santen, H. M., & Müller, H. L. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf025 · Cited by 21
Metadata
- Authors
- Boekhoff, S., Bogusz, A., Sterkenburg, A. S., Eveslage, M., & Müller, H. L.
- Affiliations
- 1Department of Pediatrics and Pediatric Hematology/Oncology, Klinikum Oldenburg AöR, Medical Campus University Oldenburg, Oldenburg, Germany
- 4Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-11
- Volume
- 179
- Issue
- 5
- Pages
- 331-341
- ISSN
- 0804-4643
- 1479-683X
- Cited by
- 65
- References
- 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo). https://app.cochat.ai/papers/10.1530/eje-18-0505
- The paper
- Boekhoff, S., Bogusz, A., Sterkenburg, A. S., Eveslage, M., & Müller, H. L. (2018). Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo). European Journal of Endocrinology. https://doi.org/10.1530/eje-18-0505
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.